(Q43771867)

26 November 2017

0 references

Regular inhaled beta-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental? (English)

1 reference

26 November 2017

Regular Inhaled Beta-Adrenergic Agonists in the Treatment of Bronchial Asthma: Beneficial or Detrimental? (English)

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/144.2.249

26 October 2022

1 reference

Nelson HS

1

1 reference

26 November 2017

Szefler SJ

2

1 reference

26 November 2017

Martin RJ

3

1 reference

26 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1677552

26 October 2022

publication date

1 August 1991

1 reference

The American Review of Respiratory Disease

26 November 2017

1 reference

26 November 2017

144

1 reference

26 November 2017

249-250

1 reference

26 November 2017

2

1 reference

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

26 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F144.2.249

Assessment of Tachyphylaxis following Prolonged Therapy of Asthma with Inhaled Albuterol Aerosol

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/144.2.249

Regular versus symptomatic aerosol bronchodilator treatment of asthma

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/144.2.249

Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/144.2.249

Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1164/AJRCCM/144.2.249

26 October 2022

Identifiers

1 reference

26 November 2017

1 reference